Sorrento lures ex-Hologic exec Herde
Sorrento Therapeutics (NSDQ:SRNE) said it lured Kevin Herde, the former vice president of global blood screening & alliance management at Hologic (NSDQ:HOLX), to be its new CFO. Read more
The post Sorrento lures ex-Hologic exec Herde | Personnel Moves April 7, 2016 appeared first on MassDevice.